abstract |
The present invention relates to methods and materials for nucleic acid delivery, vaccination, and/or treatment of cancer. More specifically, methods and materials are provided for nucleic acid delivery, vaccination, and/or cancer treatment using one or more recombinant adenoviruses (Ad) as oncolytic agents. |